Select Page

The Value of Clock Drawing Process Assessment in Screening for Mild Cognitive Impairment and Alzheimer’s Dementia

November 5, 2021 Assessment, Ahead of Print. Many clock drawing test (CDT) scoring systems focus on drawing results and lack drawing process assessments. This study created a CDT scoring procedure with drawing process assessment and explored its diagnostic value in...

Insomnia symptom severity and cognitive performance: Moderating role of APOE genotype

July 31, 2021 Abstract Introduction We evaluated whether insomnia symptom severity was associated with cognitive function, and whether this relationship was modified by biomarkers associated with Alzheimer’s disease risk. Methods We examined insomnia symptoms...

A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research

June 11, 2021 Abstract Introduction Representation of Mexican Americans in Alzheimer’s disease (AD) clinical research has been extremely poor. Methods Data were examined from the ongoing community-based, multi-ethnic Health & Aging Brain among Latino Elders...